PI: Rory Johnson

Our mission is to develop new treatments for common diseases based on RNA therapeutics. In particular, we develop oligonucleotide drugs targeting cancer-causing long non-coding RNAs (lncRNAs), which we discover using CRISPR-Cas genome-editing and bioinformatics.

We are an interdisciplinary research group based at University College Dublin, and funded by Science Foundation Ireland through the 'Future Research Leaders' programme.
 

For more information go to Projects

1/5

Gold Lab in the media

2018                                                     article here

2017                                                     article here

Science_et_Vie.jpg
naturemethodslogo.png

 Latest News